How to Play VKTX Stock Amid Manufacturing Deal With CordenPharma
Given the optimism around its obesity candidate, we believe investors should stay invested in Viking Therapeutics.
Why Viking Therapeutics Inc. (VKTX) Is Skyrocketing Today?
We recently published a list of 10 Stocks Skyrocketing Today. In this article, we are going to take a look at where Viking ...
Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped
And Novo Nordisk (NYSE: NVO) stock, down 4.9%, is the victim. Where to invest $1,000 right now? Our analyst team just ...
Viking Therapeutics’ new contract is a game changer. Here’s how much money it could bring in.
Viking Therapeutics Inc.’s stock soared 8% Wednesday, after the maker of a promising weight-loss pill secured a manufacturing ...
1VKTX : Behind the Scenes of Viking Therapeutics's Latest Options Trends
Today, Benzinga's options scanner spotted 8 options trades for Viking Therapeutics. This is not a typical pattern. The ...
The Pharma Letter3d
Viking shares slip after manufacturing deal announced
US biopharma Viking Therapeutics developing therapies for metabolic and endocrine disorders, closed Tuesday’s trading 5% ...
Truist Financial Sticks to Its Buy Rating for Viking Therapeutics (VKTX)
In a report released today, Joon Lee from Truist Financial maintained a Buy rating on Viking Therapeutics (VKTX – Research Report). The ...
Viking manufacturing agreement removes key overhang, says Morgan Stanley
After Viking Therapeutics (VKTX) announced a multi-year manufacturing agreement with CordenPharma to support the commercialization of VK2735, ...
Viking Therapeutics Is Ready For A Standalone Future
Viking announced a supply deal with CordenPharma that sets it up for a standalone path to the obesity market. Read why I ...
Viking Therapeutics: Finally, Here Comes The Buying Opportunity (Upgrade)
Viking Therapeutics remains speculative despite progress in its clinical portfolio, notably the VK2735 program for obesity.
7 Best Weight Loss Drug Stocks to Buy in 2025
The diabetes and weight loss drug market is heating up in 2025, with significant growth signs everywhere. According to a recent study from Research and Markets, industry growth is running at an ...